Shaunak Navalkissoor

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Cross Sectional

Neuroendocrine Tumors

Hodgkin Lymphoma

Prognostic Factors

Top Venues

Journal of neuroendocrinology

Endocrine-related cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Luohai Chen, Gopinath Gnanasegaran, Dalvinder Mandair, Christos Toumpanakis, Martyn Caplin, Shaunak Navalkissoor
Prognostic stratification for patients with neuroendocrine tumours receiving 177Lu-Dotatate. Endocrine-related cancer 29 (2) (2022)
Shaunak Navalkissoor, Gopinath Gnanasegaran, Ashley B Grossman
Optimisation of radioligand therapy in neuroendocrine tumours: Current and evolving evidence. Journal of neuroendocrinology 34 (11) (2022)
Shahad Alsadik, Gopinath Gnanasegaran, Luohai Chen, Ann-Marie Quigley, Dalvinder Mandair, Christos Toumpanakis, Martyn Caplin, Shaunak Navalkissoor
Single centre retrospective review of outcome of 177 Lu-DOTATATE peptide receptor radionuclide therapy in the treatment of progressive metastatic neuroendocrine tumours: Survival, toxicity, and prognostic factors. Journal of neuroendocrinology 34 (11) (2022)
Shaunak Navalkissoor, Christos Toumpanakis, Martyn Caplin, Gopinath Gnanasegaran
Treatment of neuroendocrine tumours with 177 Lu-peptide receptor radionuclide therapy: Challenging clinical scenarios and their management. Journal of neuroendocrinology 34 (4) (2022)
Aimee R Hayes, Tu Vinh Luong, Jamie Banks, Heer Shah, Jennifer Watkins, Eric Lim, Anant Patel, Ashley B Grossman, Shaunak Navalkissoor, Daniel Krell, Martyn E Caplin
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): Prevalence, clinicopathological characteristics and survival outcome in a cohort of 311 patients with well-differentiated lung neuroendocrine tumours. Journal of neuroendocrinology 34 (10) (2022)